Back
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. Regencell Bioscience Holdings Industry Stock Comparison
Buy
78
IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF
Last Price:
$98.25
Seasonality Move:
-0.95%
Sell
4
RGC
Regencell Bioscience Holdings
Last Price:
$10.37
Seasonality Move:
7.71%
Buy
78
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV)
is a Buy
Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $98.34. The Score for IVOV is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
IVOV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
4
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $10.36. The Score for RGC is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
IVOV Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $98.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $10.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.
IVOV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.25 | Buy |
Relative Strength Index (14 RSI): | 70.68 | Buy |
Chaikin Money Flow: | 10490 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.21 - 95.45) | Buy |
Bollinger Bands (100): | (88.13 - 96.17) | Buy |
RGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 42.04 | Sell |
Chaikin Money Flow: | -993288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.73 - 41.19) | Sell |
Bollinger Bands (100): | (-5.18 - 21.08) | Buy |
IVOV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 95.66 | Buy |
20-day SMA: | 94.25 | Buy |
50-day SMA: | 92.25 | Buy |
200-day SMA: | 95.18 | Buy |
8-day EMA: | 95.95 | Buy |
20-day EMA: | 94.56 | Buy |
50-day EMA: | 93.08 | Buy |
200-day EMA: | 92.99 | Buy |
RGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.5 | Sell |
20-day SMA: | 25.98 | Sell |
50-day SMA: | 15.41 | Sell |
200-day SMA: | 4.05 | Buy |
8-day EMA: | 19.63 | Sell |
20-day EMA: | 22.78 | Sell |
50-day EMA: | 17.49 | Sell |
200-day EMA: | 6.78 | Buy |
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regencell Bioscience Holdings Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |